Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 4/20 | 0.54 |
| ▸ | CYP1A1 | P04798 | 8/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CDC25A | P30304 | 1/20 | 0.36 |
| ▸ | CDC25C | P30307 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22419020 | 0.79 | POLB (0.46) | CYP1A1CYP1A2CYP1B1CYP2A6POLB | |
| SCHEMBL18731988 | 0.79 | AHR (0.63) | AHRCA1CA2POLB | |
| SCHEMBL24316389 | 0.78 | CYP1A2 (0.50) | CYP1A1CYP1A2CYP1B1CYP2A6POLB | |
| SCHEMBL23765036 | 0.78 | AHR (0.49) | AHRCYP1A1CYP1A2CYP1B1CA1 | |
| SCHEMBL28524114 | 0.77 | AHR (0.60) | AHRCA1CA2CDC25ACDC25C | |
| SCHEMBL29992590 | 0.77 | AHR (0.60) | AHRCA1CA2CDC25ACDC25C | |
| SCHEMBL26279944 | 0.77 | AHR (0.52) | AHRCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL18731991 | 0.76 | AHR (0.63) | AHRCA1CA2POLB | |
| SCHEMBL24097542 | 0.76 | AHR (0.85) | AHRCA1CA2 | |
| SCHEMBL29992010 | 0.76 | AHR (0.54) | AHRCYP1A1CYP1A2CYP1B1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, AOC2, EPCAM | AHR 3212/4885CYP1A1 1060/4885CYP1A2 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.